Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    etonogestrelum

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Organon Wins MHRA Approval Extending Nexplanon Use to Five Years
    Organon Wins MHRA Approval Extending Nexplanon Use to Five Years

    21 May 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-05-21/organon-announces-mhra-approval-extending-duration-of-use-of-nexplanon-etonogestrel-implant-68-mg-radiopaque-to-five-years-1

    PHARMIWEB
    21 May 2026
    Share Share
    Sun Pharma signs Definitive Agreement to Acquire Organon
    Sun Pharma signs Definitive Agreement to Acquire Organon

    27 Apr 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260426881370/en/Sun-Pharma-signs-Definitive-Agreement-to-Acquire-Organon

    BUSINESSWIRE
    27 Apr 2026
    Share Share
    Organon Announces FDA Approval of sNDA Extending Use of Nexplanon
    Organon Announces FDA Approval of sNDA Extending Use of Nexplanon

    17 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-17/organon-announces-us-food-and-drug-administration-approval-of-supplemental-new-drug-application-exte

    PHARMIWEB
    17 Jan 2026
    Share Share
    Mayne Pharma Generic Haloette Receives Approval in the U.S.
    Mayne Pharma Generic Haloette Receives Approval in the U.S.

    05 Aug 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211328

    FDA
    05 Aug 2022
    Share Share
    Teva Pharms USA`s Generic Etonogestrel;Ethinyl Estradiol Receives Approval In US
    Teva Pharms USA`s Generic Etonogestrel;Ethinyl Estradiol Receives Approval In US

    16 Jan 2021

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204305

    FDA
    16 Jan 2021
    Share Share
    Teva Announces Launch of a Generic Version of NuvaRing®
    Teva Announces Launch of a Generic Version of NuvaRing®

    15 Jan 2021

    // PRESS RELEASE

    https://www.tevapharm.com/news-and-media/latest-news/teva-announces-launch-of-a-generic-version-of-nuvaring-etonogestrel-and-ethinyl-estradiol-vaginal-ring/

    PRESS RELEASE
    15 Jan 2021
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.